IL-10 and CXCL10 in Urine May Predict Response to BCG Therapy in Bladder Cancer
Felix Guerrero-Ramos, PhD, discusses the results from an analysis of IL-10 and CXCL10 in urine as useful biomarkers of response to bacillus Calmette-Guerin in patients with bladder cancer.